FridayMar 15, 2013 9:38 am

Scientific Reports Publishes International Stem Cell Corp. (ISCO) Technology for Deriving Neuronal Cell

International Stem Cell Corp., a biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSC), this morning told investors that its breakthrough method of deriving neuronal cells for the treatment of Parkinson's disease has been published in Scientific Reports, a primary research publication from the publishers of Nature Publishing Group. Parkinson's disease (PD) is a common neurodegenerative disorder caused by a progressive loss of dopamine-producing neurons resulting in gradual dysfunction of the motor system. Pharmacological treatments are useful in the relatively early stage of the disease, but the continuous use of pro-dopaminergic medication eventually becomes ineffective and…

Continue Reading

FridayMar 15, 2013 8:40 am

Denison Mines Corp. (DNN) Details Recent Exploration Work, New Mineralization Area Identified at Wheeler River

Denison Mines, a primarily uranium developer with interests in Canada, Mongolia, and Zimbabwe, including the world-class Phoenix deposits at Wheeler River (60%-owned), with over 1.31M acres in Saskatchewan's Eastern Athabasca Basin, reported yesterday that the company has intersected some choice mineralization just north of the Phoenix deposits at Wheeler, as well as high-grade mineralization in the infill drill holes. Also in the report is news about the 7,776 feet of drilling in thirteen holes at the Hatchet Lake property (50%-owned) up in the northeastern Athabasca. Originally only 11 holes were planned but they just had to get in two more…

Continue Reading

FridayMar 15, 2013 8:24 am

GlobalWise Investments, Inc. (GWIV) Offers Flexible ECM Deployment

GlobalWise Investments, provider of ECM (Enterprise Content Management) systems to businesses and organizations through its subsidiary Intellinetics, is a pathfinder in the use of cloud related technologies. The company’s ECM solutions allow users to gain control over what has become for many a chaotic world of poorly organized stored documents, records that can be important but that can easily be lost in the volumes of paper that are processed every day. Using advanced software, which can be easily integrated with host business applications and copy/scanning procedures, documents become easily accessed and available for carefully secured access on a 24/7 basis…

Continue Reading

FridayMar 15, 2013 8:13 am

Bergamo Acquisition Corp. (BGMO) Solar Pumping System Does Heavy Lifting

It wasn’t that many years ago when solar power was hard to consider as a serious mainstream energy source, with what were then low-efficiency solar collectors and crude support technologies. Today, even though continuing technological breakthroughs and large scale installations have turned that impression around, there is still a sense that small remotely based solar PV systems are only good for powering low-consumption electronics, and that such systems are not yet ready to do any “heavy lifting.” Bergamo Energy, a Florida-based subsidiary of international holding company Bergamo Acquisition Corp., is a good example of how remotely stationed solar capabilities have…

Continue Reading

ThursdayMar 14, 2013 3:58 pm

Diego Salazar Joins Spartan Motors, Inc. (SPAR) Division as Director of Latin American Sales

Today, Spartan ERV, a business unit of Spartan Motors, announced that Diego Salazar has joined the company as its Director of Latin American Sales. Based in Santiago, Chile, Mr. Salazar will focus on supporting business development activities in Spartan ERV’s Latin American market. The hiring marks the latest in a series of investments to accelerate the development of the sales pipeline in South America. With over 20 years of international business experience, Mr. Salazar has spent time in Brazil, England, Chile, and the United States. Mr. Salazar joins Spartan ERV after several years with Roche Pharmaceuticals, one of the largest…

Continue Reading

ThursdayMar 14, 2013 3:00 pm

The Guitammer Company, Inc. (GTMM) Revenues Up 64% with Higher Gross Profit and Stronger Balance Sheet

The Guitammer Company, a company well known for its low frequency audio transducers that provide an immersive “4D” entertainment experience, just reported strong financial results for the full year ending December 31, 2012. Financial Highlights and Recent Developments • Revenues totaled $2.13 million, up 64 percent year-over-year, with a gross margin of 40 percent. • Gross profit rose 55 percent to approximately $850,000 as compared to FY2011. • Approximately $1.7 million was raised in private placements in FY2012, providing Guitammer with capital for ambitious growth initiatives. • Continued an expanding relationship with China-based Sichuan Lumiere Cinema Co. Ltd. (Lumière Pavilions)…

Continue Reading

ThursdayMar 14, 2013 2:44 pm

The Aristocrat Group Corp. (ASCC) Lays Foundation to Repeat Tito’s All-American Success Story

Although the $1.2 billion super-premium vodka market in the U.S. keeps on growing every day, the stiff competition for vodka-drinkers’ dollars leaves many emerging producers badly in need of a drink. That’s why the Aristocrat Group Corp.’s brand management division, Luxuria Brands, is pouring time and effort into replicating an all-American, brand-building success story with its new vodka line. In a market largely dominated by imports—Holland’s Ketel One, France’s Grey Goose, Sweden’s Absolut and more—Tito’s Handmade Vodka has blazed a path to success without a pretty name, fancy bottle or million-dollar ad budget. Founded back in 1997 by entrepreneur Bert…

Continue Reading

ThursdayMar 14, 2013 2:20 pm

GenSpera, Inc. (GNSZ) Receives Orphan Drug Designation for Lead Candidate G-202 for Treatment of Liver Cancer

The U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation to GenSpera’s lead candidate G-202 for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. G-202, currently in a phase 2 clinical trial for patients whose disease has worsened on standard therapy for HCC, is expected to demonstrate efficacy in a wide range of tumor types. By receiving Orphan drug designation for G-202, GNSZ is granted seven-year U.S. market exclusivity if the company complies with certain FDA specifications. Additional incentives include tax credits for clinical trial expenses, access to…

Continue Reading

ThursdayMar 14, 2013 10:19 am

Viscount Systems, Inc. (VSYS) Secures Connecticut School with Freedom

Viscount Systems, a leading-edge supplier of security systems and software, today announced that its Freedom access control solution has been installed at a private faith-based K-12 school in Connecticut. “We are pleased to continue making progress in the school security market,” stated Stephen Pineau, CEO of Viscount Systems. “Our technology enables schools to more securely control access to their facilities, at a significantly reduced cost versus traditional systems. This enables schools to either reduce the cost of securing each facility or to expand security within the same budget.” “We continue to build new applications to solve the issues facing school…

Continue Reading

ThursdayMar 14, 2013 9:34 am

Cardium Therapeutics, Inc. (CXM) Excellagen Wound Care Product Receives ISO Certification

Today before the bell, Cardium Therapeutics announced that it has received ISO 13485:2003 certification for its Excellagen® advanced wound care product by BSI, one of the world's leading certification bodies. This certification is a stand-alone standard developed by the International Organization for Standardization that provides harmonized quality management systems requirements for manufacturers of medical devices. Cardium's compliance with ISO 13485 represents an important next step forward to compliance with European regulatory requirements. "This ISO certification represents a major achievement and milestone for Cardium and moves us forward in our CE Mark Certification application for authorization to market and sell Excellagen…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered